Focus
What’s Actually in Your Cigarette: The 599 Additives Designed to Make It Impossible to Quit
You are not addicted to tobacco. You are addicted to a pharmaceutical delivery system that was engineered in the 1960s to hit the brain faster than heroin, stay longer than the tobacco alone would allow, and feel smooth enough that a teenager would keep going. The anxiety you feel between cigarettes is not withdrawal from nicotine. It is withdrawal from a drug stack the cigarette was designed to create.
In 1994, the major tobacco companies submitted a list of 599 additives to the United States Department of Health and Human Services. The list had been kept from the public until ABC News obtained and broadcast it in March of that year. The companies described the additives as flavor enhancers, humectants, and burn regulators, compounds that kept tobacco moist, made smoke smoother, and made the burn more even. What the list did not explain, and what internal company documents obtained through litigation later confirmed, is that the primary purpose of the most consequential additives was pharmacological: to alter how nicotine was delivered to the brain, how quickly it arrived, how intensely it hit, and how completely the brain became dependent on the cycle.
The standard cigarette contains roughly 10 percent additives by weight. Most of that weight is sugars, humectants, ammonia compounds, cocoa, and licorice. Each of these has a flavor function. Each also has a pharmacological one that the flavor function was used to disguise in regulatory filings for decades.
The ammonia technology Philip Morris kept secret for thirty years
In the early 1960s Philip Morris discovered that adding ammonia compounds to tobacco changed the chemistry of nicotine in the smoke. Nicotine exists in two forms: a salt form, which is bound and slow to absorb, and a freebase form, which is volatile, crosses biological membranes rapidly, and reaches the brain within seconds. Ammonia raises the pH of the smoke, shifting nicotine from its salt form to its freebase form. The result is a faster, harder neurological impact from the same amount of nicotine. The company’s own internal documents described this as the secret and soul of Marlboro. Competitors spent years trying to reverse-engineer why Marlboro outsold every other brand. The answer was crack nicotine.
Freebasing is the same chemical process used to convert cocaine into crack cocaine. The FDA made this explicit in its 1996 regulatory filings, noting that compounds in freebase form are absorbed more readily than compounds in salt form and citing nicotine and cocaine as parallel examples. Philip Morris had been doing this industrially since the early 1960s. It remained a company secret until the 1970s and an industry secret until a Pulitzer Prize winning Wall Street Journal investigation broke it in 1995. The 1999 industry statement to regulators denied that ammonia technology increased nicotine delivery. The internal documents said otherwise. A research paper published in the American Journal of Public Health in 2008 documented the full history from the company’s own records.
What the sugars do when they burn
Added sugars make tobacco smoke smoother and easier to inhale, which lowers the natural deterrent that harsh smoke provides to new smokers. When the sugars burn, they produce acetaldehyde. Acetaldehyde has two documented effects on addiction. First, it enhances nicotine’s addictive impact directly by activating reward pathways in the brain through a separate mechanism from nicotine. Philip Morris’s own research documented a synergistic effect on addictive behavior in animal studies. Second, acetaldehyde reacts with compounds in the smoke to form harman and norharman, beta-carboline alkaloids that inhibit monoamine oxidase in the brain.
Monoamine oxidase breaks down dopamine, serotonin, and norepinephrine. When MAO is inhibited, these neurotransmitters accumulate. PET scan studies have confirmed that smokers have 30 to 40 percent lower MAO activity in the brain than non-smokers. This is the same mechanism as antidepressant drugs in the MAOI class. Every cigarette is delivering a mild antidepressant effect through the sugar combustion chemistry, in addition to the nicotine. When you stop smoking, or when you switch to a cigarette without added sugars, MAO activity recovers. The neurochemical environment shifts. What most people experience as the emotional difficulty of quitting is not nicotine withdrawal alone. It is the withdrawal from a continuous mild antidepressant effect that the cigarette was engineering through its additive chemistry.
Why some cigarettes cause more anxiety than others
The freebase nicotine spike from ammonia technology is faster and sharper than the nicotine delivery from unadulterated tobacco. A sharper spike produces a steeper drop. The steeper the drop between cigarettes, the more pronounced the anxiety and craving in the trough. Smokers who report that certain brands make them anxious, and that switching to additive-free tobacco reduced that anxiety, are describing a real pharmacological phenomenon. The anxiety is not psychological sensitivity. It is the withdrawal profile of a faster-hitting drug. The brand with the most aggressive ammonia technology produces the most pronounced trough. The additive-free cigarette delivers nicotine more slowly, more steadily, and drops off less steeply. The neurological ride is different. The anxiety is different.
To be precise about what additive-free means in this context: it means the absence of the engineered pharmacological stack. It does not mean safe. Tobacco combustion produces tar, carbon monoxide, and over 60 carcinogens regardless of what additives are present. Additive-free cigarettes are still harmful. What they do not contain is the ammonia technology that freebase the nicotine, the added sugars that produce the MAO-inhibiting beta-carbolines, and the levulinic acid that increases nicotine binding at receptor sites in the brain. The addiction without the stack is a different and somewhat less engineered dependency. The health consequences of the tobacco itself remain the same.
The design document
The 599 additive list submitted in 1994 was not a safety disclosure. It was a list of ingredients approved as safe for use in food. The tobacco companies used that approval status to argue that their additives were benign, because each one had been cleared for human consumption. What the food safety approval did not test, and what the companies knew, is what happens when these compounds are burned. Burning changes chemistry. The food-safe sugar becomes acetaldehyde. The food-safe ammonia compound becomes the freebasing agent. The food-safe levulinic acid becomes the receptor binding enhancer. The regulatory framework evaluated the ingredients. The product delivers the combustion chemistry. The gap between those two things was the design space the industry worked in for sixty years.
The Campaign for Tobacco-Free Kids titled their 2014 report on cigarette design Designed for Addiction. That is the accurate description. A 90 percent market share of adult smokers who started before age 18. A product deliberately engineered to be smooth enough for first use, addictive enough to sustain use, and chemically constructed to make cessation harder than the drug itself would require. The 599 additives were not incidental to that design. They were the mechanism of it.
How sugar suppresses your immune system /
How corporations got the rights of people without the consequences /
If a corporation is a person, why can’t it go to jail
- Stevenson T, Proctor RN (2008). The secret and soul of Marlboro: Phillip Morris and the origins, spread, and denial of nicotine freebasing. American Journal of Public Health. 98(7):1184-1194.
- Freedman A (1995). Pulitzer Prize winning investigation into Philip Morris ammonia technology. Wall Street Journal.
- Connolly GN et al. (2007). Pharmacological and chemical effects of cigarette additives. American Journal of Public Health. 97(11).
- FDA (1996). Regulations restricting sale and distribution of cigarettes. Documents freebase nicotine and cocaine as parallel examples of absorption enhancement.
- List of additives in cigarettes (1994). Submitted to US Department of Health and Human Services. 599 additives. First released publicly by ABC News Day One, March 7, 1994.
- Herraiz T, Chaparro C (2005). Human monoamine oxidase is inhibited by tobacco smoke. FEBS Letters. 579(17):3846-3852.
- Fowler JS et al. (1996). Brain monoamine oxidase A inhibition in cigarette smokers. PNAS. 93(24):14065-14069.
- Campaign for Tobacco-Free Kids (2014). Designed for Addiction. tobaccofreekids.org
- Keithly L et al. (2005). Industry research on the use and effects of levulinic acid. Nicotine and Tobacco Research. 7(5):761-71.